Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
DBV Technologies
Download detailed PDF Members: DBV Technologies (DBV) is a speciality pharma company specialising in the development of non-invasive epicutaneous diagnostics and immunotherapies for allergy diagnosis and treatment. The Company is lead by CEO Jean-François Biry and was born out of the experience of Professor Christophe Dupont, a paediatric GI, from Assistance Publique-Hôpitaux de Paris and Université Paris Descartes, Doctor Pierre-Henri Benhamou, a paediatrician specialising in gastro-enterology, allergosis and nutrition, and Bertrand Dupont, a qualified engineer from the Arts et Métiers Institute. DBV Technologies’ lead product, Diallertest® Milk, is on sale in France and other countries for the diagnosis of cow’s milk protein allergy.
This page has been viewed 43 times since April 2007, the link to the organisation's website has been followed 0 times Search for more companies in Paris This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for DBV Technologies | ||||||||||||||||||||||||||||||||||||
|